Pub Date : 2017-07-01DOI: 10.1016/j.rppnen.2017.01.008
P.S. Santos , M.A. Marques , C. Cruz , H. Monteiro , F. Fradinho
Introduction
Malignant pleural effusions are an important burden of malignant disease. Slurry talc pleurodesis remains one of the most common and effective therapeutic options.
Aim
Investigate the predictive factors related with the efficacy of this technique in malignant pleural effusions.
Methods
Retrospective analysis of all pleurodesis performed during a 10-year period in a Pulmonology Unit. All demographic and clinical data were collected, including the histologic tumoral type and the biochemical, microbiological and cytological fluid features. Efficacy was defined as the lack of recurrence of pleural effusion. It was used Kaplan–Meyer analysis to estimate overall survival.
Results
From a total of 202 patients submitted to pleurodesis (47% men; mean age 66.9 ± 12.02 years). Light's criteria identified 86.6% as exudates. We found 85.1% survival at 30-day post-pleurodesis, which means the therapy used has significant success. A logistic regression model applied explained that variance in post-pleurodesis events was mostly due to age and gender rather than pleural biochemical factors (X2(5) = 44.648, p < 0.001, R2 28.3%).
Conclusion
This study suggests that clinical evaluation of biochemical values, bacteriological results and malignant tumor diagnosis may not be enough to predict post-pleurodesis relapse with high accuracy. Furthermore, we observed, in ten years of pleurodesis performed in our Hospital, that pleurodesis is an effective life prolonging therapy for patients that fit the criteria for this intervention.
恶性胸腔积液是恶性疾病的重要负担。滑石粉浆液胸膜固定术仍然是最常见和有效的治疗选择之一。目的探讨影响该技术治疗恶性胸腔积液疗效的相关预测因素。方法回顾性分析某肺科10年间所有胸膜切除术病例。收集了所有的人口学和临床资料,包括肿瘤的组织学类型和生化、微生物学和细胞学的液体特征。疗效的定义是没有复发的胸腔积液。采用Kaplan-Meyer分析估计总生存率。结果202例患者中,47%为男性;平均年龄(66.9±12.02岁)。Light的标准确定86.6%为渗出物。我们发现胸膜切除术后30天生存率为85.1%,这意味着所采用的治疗方法取得了显著的成功。应用logistic回归模型解释胸膜切除术后事件的差异主要是由于年龄和性别,而不是胸膜生化因素(X2(5) = 44.648, p <0.001, r2 28.3%)。结论临床评价生化指标、细菌学结果和恶性肿瘤诊断可能不足以准确预测胸膜切除术后复发。此外,我们观察到,在我院进行的10年胸膜切除术中,胸膜切除术是一种有效的延长患者生命的治疗方法,符合这种干预标准。
{"title":"Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions","authors":"P.S. Santos , M.A. Marques , C. Cruz , H. Monteiro , F. Fradinho","doi":"10.1016/j.rppnen.2017.01.008","DOIUrl":"10.1016/j.rppnen.2017.01.008","url":null,"abstract":"<div><h3>Introduction</h3><p>Malignant pleural effusions are an important burden of malignant disease. Slurry talc pleurodesis remains one of the most common and effective therapeutic options.</p></div><div><h3>Aim</h3><p>Investigate the predictive factors related with the efficacy of this technique in malignant pleural effusions.</p></div><div><h3>Methods</h3><p>Retrospective analysis of all pleurodesis performed during a 10-year period in a Pulmonology Unit. All demographic and clinical data were collected, including the histologic tumoral type and the biochemical, microbiological and cytological fluid features. Efficacy was defined as the lack of recurrence of pleural effusion. It was used Kaplan–Meyer analysis to estimate overall survival.</p></div><div><h3>Results</h3><p>From a total of 202 patients submitted to pleurodesis (47% men; mean age 66.9<!--> <!-->±<!--> <!-->12.02 years). Light's criteria identified 86.6% as exudates. We found 85.1% survival at 30-day post-pleurodesis, which means the therapy used has significant success. A logistic regression model applied explained that variance in post-pleurodesis events was mostly due to age and gender rather than pleural biochemical factors (<em>X</em><sup>2</sup><sub>(5)</sub> <!-->=<!--> <!-->44.648, <em>p</em> <!--><<!--> <!-->0.001, <em>R</em><sup>2</sup> 28.3%).</p></div><div><h3>Conclusion</h3><p>This study suggests that clinical evaluation of biochemical values, bacteriological results and malignant tumor diagnosis may not be enough to predict post-pleurodesis relapse with high accuracy. Furthermore, we observed, in ten years of pleurodesis performed in our Hospital, that pleurodesis is an effective life prolonging therapy for patients that fit the criteria for this intervention.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 216-220"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.01.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35081711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-01DOI: 10.1016/j.rppnen.2017.02.005
Paulo D. Vitória , Célia Nunes , José Precioso
Second-hand tobacco smoke (SHS) exposure is a major and entirely avoidable health risk for children's health, well-being and development. The main objective of the current study was to investigate the association between parents’ educational level and children's SHS home exposure.
A self-administered questionnaire was conducted within a sample of 949 students in 4th grade (mean age 9.56 ± 0.75, 53.4% male). The sample was randomly selected from all schools located at Lisbon District, Portugal.
The current study confirmed that Portuguese children are exposed to unacceptable high levels of SHS at home, mainly by their parents’ smoke. Prevalence of smokers was higher amongst parents with low educational level. Children of parents with low educational level were more likely to suffer SHS exposure at home. These results confirmed the social inequalities associated with smoking, support the relevance of more research on this subject and stress the need for more interventions to control this problem. Some interventions should be specifically aimed at less educated parents, particularly at less educated mothers.
{"title":"Parents’ educational level and second-hand tobacco smoke exposure at home in a sample of Portuguese children","authors":"Paulo D. Vitória , Célia Nunes , José Precioso","doi":"10.1016/j.rppnen.2017.02.005","DOIUrl":"10.1016/j.rppnen.2017.02.005","url":null,"abstract":"<div><p>Second-hand tobacco smoke (SHS) exposure is a major and entirely avoidable health risk for children's health, well-being and development. The main objective of the current study was to investigate the association between parents’ educational level and children's SHS home exposure.</p><p>A self-administered questionnaire was conducted within a sample of 949 students in 4th grade (mean age 9.56<!--> <!-->±<!--> <!-->0.75, 53.4% male). The sample was randomly selected from all schools located at Lisbon District, Portugal.</p><p>The current study confirmed that Portuguese children are exposed to unacceptable high levels of SHS at home, mainly by their parents’ smoke. Prevalence of smokers was higher amongst parents with low educational level. Children of parents with low educational level were more likely to suffer SHS exposure at home. These results confirmed the social inequalities associated with smoking, support the relevance of more research on this subject and stress the need for more interventions to control this problem. Some interventions should be specifically aimed at less educated parents, particularly at less educated mothers.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 221-224"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.02.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34859524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-01DOI: 10.1016/j.rppnen.2017.02.004
M.J. Guimarães , J.C. Winck , B. Conde , A. Mineiro , M. Raposo , J. Moita , A. Marinho , J.M. Silva , N. Pires , S. André , C. Loureiro
Pompe disease is a rare autosomal recessive neuromuscular disorder caused by acid α-glucosidase enzyme (GAA) deficiency and divided into two distinct variants, infantile- and late-onset. The late-onset variant is characterized by a spectrum of phenotypic variation that may range from asymptomatic, to reduced muscle strength and/or diaphragmatic paralysis. Since muscle strength loss is characteristic of several different conditions, which may also cause diaphragmatic paralysis, a protocol was created to search for the diagnosis of Pompe disease and exclude other possible causes.
Methods
We collected a sample size of 18 patients (10 females, 8 males) with a median age of 60 years and diagnosis of diaphragmatic paralysis of unknown etiology, followed in the Pulmonology outpatient consultation of 9 centers in Portugal, over a 24-month study period. We evaluated data from patient's clinical and demographic characteristics as well as complementary diagnostic tests including blood tests, imaging, neurophysiologic and respiratory function evaluation. All patients were evaluated for GAA activity with DBS (dried blood test) or serum quantification and positive results confirmed by serum quantification and sequencing.
Results
Three patients were diagnosed with Pompe's disease and recommended for enzyme replacement therapy. The prevalence of Pompe, a rare disease, in our diaphragmatic paralysis patient sample was 16.8%.
Conclusion
We conclude that DBS test for GAA activity should be recommended for all patients with diaphragmatic paralysis which, despite looking at all the most common causes, remains of unknown etiology; this would improve both the timing and accuracy of diagnosis for Pompe disease in this patient population. Accurate diagnosis will lead to improved care for this rare, progressively debilitating but treatable neuromuscular disease.
{"title":"Prevalence of late-onset pompe disease in Portuguese patients with diaphragmatic paralysis – DIPPER study","authors":"M.J. Guimarães , J.C. Winck , B. Conde , A. Mineiro , M. Raposo , J. Moita , A. Marinho , J.M. Silva , N. Pires , S. André , C. Loureiro","doi":"10.1016/j.rppnen.2017.02.004","DOIUrl":"10.1016/j.rppnen.2017.02.004","url":null,"abstract":"<div><p>Pompe disease is a rare autosomal recessive neuromuscular disorder caused by acid α-glucosidase enzyme (GAA) deficiency and divided into two distinct variants, infantile- and late-onset. The late-onset variant is characterized by a spectrum of phenotypic variation that may range from asymptomatic, to reduced muscle strength and/or diaphragmatic paralysis. Since muscle strength loss is characteristic of several different conditions, which may also cause diaphragmatic paralysis, a protocol was created to search for the diagnosis of Pompe disease and exclude other possible causes.</p></div><div><h3>Methods</h3><p>We collected a sample size of 18 patients (10 females, 8 males) with a median age of 60 years and diagnosis of diaphragmatic paralysis of unknown etiology, followed in the Pulmonology outpatient consultation of 9 centers in Portugal, over a 24-month study period. We evaluated data from patient's clinical and demographic characteristics as well as complementary diagnostic tests including blood tests, imaging, neurophysiologic and respiratory function evaluation. All patients were evaluated for GAA activity with DBS (dried blood test) or serum quantification and positive results confirmed by serum quantification and sequencing.</p></div><div><h3>Results</h3><p>Three patients were diagnosed with Pompe's disease and recommended for enzyme replacement therapy. The prevalence of Pompe, a rare disease, in our diaphragmatic paralysis patient sample was 16.8%.</p></div><div><h3>Conclusion</h3><p>We conclude that DBS test for GAA activity should be recommended for all patients with diaphragmatic paralysis which, despite looking at all the most common causes, remains of unknown etiology; this would improve both the timing and accuracy of diagnosis for Pompe disease in this patient population. Accurate diagnosis will lead to improved care for this rare, progressively debilitating but treatable neuromuscular disease.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 208-215"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.02.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34991170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-01DOI: 10.1016/j.rppnen.2017.02.010
A. Feliciano , M.J. Oliveira , A. Cysneiros , C. Martinho , R.P. Reis , D. Penque , P. Pinto , C. Bárbara
Introduction
Obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular/metabolic complications. Some analytical parameters (homocysteine, glycemic and lipidic profiles) are recognized markers of these consequences. Limited data is available on the association of these markers and OSAS's severity/response to positive airway pressure therapy (PAP).
Material and methods
In this prospective study we analyzed polysomnographic and analytical data of male patients admitted to sleep laboratory. The aim was to evaluate metabolic/cardiovascular markers in snorers and OSAS patients, to relate with sleep parameters and PAP response. One-hundred and three patients were included, and 73 (71%) were OSAS patients. OSAS patients were similar to snorers except for higher body mass index (BMI) and dyslipidemia. Severe OSAS patients showed higher glycemia, HbA1c, insulin, and insulin resistance, and lower HDL cholesterol in comparison to mild–moderate (p < 0.05, p < 0.05, p < 0.001, p < 0.001, p < 0.05, respectively). Glycemic profile and triglycerides were slightly correlated with OSAS severity. 46 OSAS patients were submitted to 6 months of PAP, with a statistical decrease in mean values of homocysteine, glycemia, total and LDL cholesterol (p < 0.05, p < 0.05, p < 0.05, respectively), and in glycemia and LDL cholesterol in severe group only (p < 0.05, p < 0.05, respectively).
Results
This study demonstrated an association between glucose metabolism parameters and triglycerides with OSAS severity underlying the complexity of the process leading to cardiovascular/metabolic complications in this disorder. Moreover, homocysteine, glycemic and lipidic profiles changed significantly after 6 months of PAP therapy in OSAS, supporting its cardiovascular and metabolic protective effect.
Conclusion
Our study has reinforced the importance of analytical cardiovascular/metabolic evaluation as complementary tool of diagnosis/treatment response in OSAS.
阻塞性睡眠呼吸暂停综合征(OSAS)与心血管/代谢并发症相关。一些分析参数(同型半胱氨酸、血糖和血脂谱)被认为是这些后果的标志。这些标志物与OSAS严重程度/对气道正压治疗(PAP)的反应之间的关联数据有限。材料与方法在本前瞻性研究中,我们分析了睡眠实验室收治的男性患者的多导睡眠图和分析数据。目的是评估打鼾者和OSAS患者的代谢/心血管标志物,与睡眠参数和PAP反应相关。纳入103例患者,其中73例(71%)为OSAS患者。OSAS患者除了身体质量指数(BMI)较高和血脂异常外,与打鼾者相似。与轻度-中度OSAS患者相比,重度OSAS患者表现出更高的血糖、HbA1c、胰岛素和胰岛素抵抗,以及更低的高密度脂蛋白胆固醇(p <0.05, p <0.05, p <0.001, p <0.001, p <分别为0.05)。血糖谱和甘油三酯与OSAS严重程度略有相关。46例OSAS患者接受6个月的PAP治疗,同型半胱氨酸、血糖、总胆固醇和低密度脂蛋白胆固醇的平均值均有统计学意义下降(p <0.05, p <0.05, p <0.05),严重组血糖和低密度脂蛋白胆固醇(p <0.05, p <分别为0.05)。结果本研究表明葡萄糖代谢参数和甘油三酯与OSAS严重程度之间存在关联,这一过程的复杂性导致了这种疾病的心血管/代谢并发症。此外,在osa患者接受PAP治疗6个月后,同型半胱氨酸、血糖和血脂谱发生了显著变化,支持其心血管和代谢保护作用。结论本研究强化了分析性心血管/代谢评价作为OSAS诊断/治疗反应补充工具的重要性。
{"title":"Effects of positive airway pressure therapy on cardiovascular and metabolic markers in males with obstructive sleep apnea","authors":"A. Feliciano , M.J. Oliveira , A. Cysneiros , C. Martinho , R.P. Reis , D. Penque , P. Pinto , C. Bárbara","doi":"10.1016/j.rppnen.2017.02.010","DOIUrl":"10.1016/j.rppnen.2017.02.010","url":null,"abstract":"<div><h3>Introduction</h3><p>Obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular/metabolic complications. Some analytical parameters (homocysteine, glycemic and lipidic profiles) are recognized markers of these consequences. Limited data is available on the association of these markers and OSAS's severity/response to positive airway pressure therapy (PAP).</p></div><div><h3>Material and methods</h3><p>In this prospective study we analyzed polysomnographic and analytical data of male patients admitted to sleep laboratory. The aim was to evaluate metabolic/cardiovascular markers in snorers and OSAS patients, to relate with sleep parameters and PAP response. One-hundred and three patients were included, and 73 (71%) were OSAS patients. OSAS patients were similar to snorers except for higher body mass index (BMI) and dyslipidemia. Severe OSAS patients showed higher glycemia, HbA1c, insulin, and insulin resistance, and lower HDL cholesterol in comparison to mild–moderate (<em>p</em> <!--><<!--> <!-->0.05, <em>p</em> <!--><<!--> <!-->0.05, <em>p</em> <!--><<!--> <!-->0.001, <em>p</em> <!--><<!--> <!-->0.001, <em>p</em> <!--><<!--> <!-->0.05, respectively). Glycemic profile and triglycerides were slightly correlated with OSAS severity. 46 OSAS patients were submitted to 6 months of PAP, with a statistical decrease in mean values of homocysteine, glycemia, total and LDL cholesterol (<em>p</em> <!--><<!--> <!-->0.05, <em>p</em> <!--><<!--> <!-->0.05, <em>p</em> <!--><<!--> <!-->0.05, respectively), and in glycemia and LDL cholesterol in severe group only (<em>p</em> <!--><<!--> <!-->0.05, <em>p</em> <!--><<!--> <!-->0.05, respectively).</p></div><div><h3>Results</h3><p>This study demonstrated an association between glucose metabolism parameters and triglycerides with OSAS severity underlying the complexity of the process leading to cardiovascular/metabolic complications in this disorder. Moreover, homocysteine, glycemic and lipidic profiles changed significantly after 6 months of PAP therapy in OSAS, supporting its cardiovascular and metabolic protective effect.</p></div><div><h3>Conclusion</h3><p>Our study has reinforced the importance of analytical cardiovascular/metabolic evaluation as complementary tool of diagnosis/treatment response in OSAS.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 193-202"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.02.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35073498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-01DOI: 10.1016/j.rppnen.2017.03.003
C. Cruz , M. Afonso , B. Oliveiros , A. Pêgo
{"title":"Survival analysis of patients with non-small cell lung cancer treated by surgery with curative intent","authors":"C. Cruz , M. Afonso , B. Oliveiros , A. Pêgo","doi":"10.1016/j.rppnen.2017.03.003","DOIUrl":"10.1016/j.rppnen.2017.03.003","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 230-232"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.03.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35029179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}